Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial.
Conclusion: The present meta-analysis indicated the effects of imiquimod in improving the histological/composite clearance rates as compared with other treatments.
PMID: 31294669 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
More News: Basal Cell Carcinoma | Cancer & Oncology | Carcinoma | Databases & Libraries | Dermatology | Science | Skin | Skin Cancer | Study